Request for Covid-19 Impact Assessment of this Report

Pharmaceuticals

United States Polysaccharide vaccines Industry 2016 Deep Market Research Report

  • QYR589184
  • 137 Pages
  • June 2016
  • Pharmaceuticals
Download Sample    Get Discount   
 
The United States Polysaccharide vaccines Industry 2016 Market Research Report is a professional and in-depth study on the current state of the Polysaccharide vaccines industry.

The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. The Polysaccharide vaccines market analysis is provided for the United States markets including development trends, competitive landscape analysis, and key regions development status.

Development policies and plans are discussed as well as manufacturing processes and Bill of Materials cost structures are also analyzed. This report also states import/export consumption, supply and demand Figures, cost, price, revenue and gross margins.

The report focuses on United States major leading industry players providing information such as company profiles, product picture and specification, capacity, production, price, cost, revenue and contact information. Upstream raw materials and equipment and downstream demand analysis is also carried out. The Polysaccharide vaccines industry development trends and marketing channels are analyzed. Finally the feasibility of new investment projects are assessed and overall research conclusions offered.

With 157 tables and figures the report provides key statistics on the state of the industry and is a valuable source of guidance and direction for companies and individuals interested in the market.

Table of Contents

1 Industry Overview

1.1 Definition and Specifications of Polysaccharide vaccines

1.1.1 Definition of Polysaccharide vaccines

1.1.2 Specifications of Polysaccharide vaccines

1.2 Classification of Polysaccharide vaccines

1.3 Applications of Polysaccharide vaccines

1.4 Industry Chain Structure of Polysaccharide vaccines

1.5 Industry Overview of Polysaccharide vaccines

1.6 Industry Policy Analysis of Polysaccharide vaccines

1.7 Industry News Analysis of Polysaccharide vaccines

2 Manufacturing Cost Structure Analysis of Polysaccharide vaccines

2.1 Bill of Materials (BOM) of Polysaccharide vaccines

2.2 BOM Price Analysis of Polysaccharide vaccines

2.3 Labor Cost Analysis of Polysaccharide vaccines

2.4 Depreciation Cost Analysis of Polysaccharide vaccines

2.5 Manufacturing Cost Structure Analysis of Polysaccharide vaccines

2.6 Manufacturing Process Analysis of Polysaccharide vaccines

2.7 United States Price, Cost and Gross of Polysaccharide vaccines 2011-2016

3 Technical Data and Manufacturing Plants Analysis

3.1 Capacity and Commercial Production Date of United States Key Manufacturers in 2015

3.2 Manufacturing Plants Distribution of United States Key Polysaccharide vaccines Manufacturers in 2015

3.3 R&D Status and Technology Source of United States Polysaccharide vaccines Key Manufacturers in 2015

3.4 Raw Materials Sources Analysis of United States Polysaccharide vaccines Key Manufacturers in 2015

4 Production Analysis of Polysaccharide vaccines by Regions, Type, and Applications

4.1 United States Production of Polysaccharide vaccines by Regions 2011-2016

4.2 United States Production of Polysaccharide vaccines by Type 2011-2016

4.3 United States Sales of Polysaccharide vaccines by Applications 2011-2016

4.4 Price Analysis of United States Polysaccharide vaccines Key Manufacturers in 2015

4.5 United States Capacity, Production, Import, Export, Sales, Price, Cost and Revenue of Polysaccharide vaccines 2011-2016

5 Consumption Volume and Consumption Value Analysis of Polysaccharide vaccines by Regions

5.1 United States Consumption Volume of Polysaccharide vaccines by Regions 2011-2016

5.2 United States Consumption Value of Polysaccharide vaccines by Regions 2011-2016

5.3 United States Consumption Price Analysis of Polysaccharide vaccines by Regions 2011-2016

6 Analysis of Polysaccharide vaccines Production, Supply, Sales and Market Status 2011-2016

6.1 Capacity, Production, Sales, and Revenue of Polysaccharide vaccines 2011-2016

6.2 Production Market Share and Sales Market Share Analysis of Polysaccharide vaccines 2014-2015

6.3 Sales Overview of Polysaccharide vaccines 2011-2016

6.4 Supply, Consumption and Gap of Polysaccharide vaccines 2011-2016

6.5 Import, Export and Consumption of Polysaccharide vaccines 2011-2016

6.6 Cost, Price, Revenue and Gross Margin of Polysaccharide vaccines 2011-2016

7 Analysis of Polysaccharide vaccines Industry Key Manufacturers

7.1 GSK

7.1.1 Company Profile

7.1.2 Product Picture and Specifications

7.1.2.1 Type I

7.1.2.2 Type II

7.1.2.3 Type III

7.1.3 Capacity, Production, Price, Cost, Gross and Revenue

7.1.4 Contact Information

7.2 Merck

7.2.1 Company Profile

7.2.2 Product Picture and Specifications

7.2.2.1 Type I

7.2.2.2 Type II

7.2.2.3 Type III

7.2.3 Capacity, Production, Price, Cost, Gross and Revenue

7.2.4 Contact Information

7.3 Novartis

7.3.1 Company Profile

7.3.2 Product Picture and Specifications

7.3.2.1 Type I

7.3.2.2 Type II

7.3.2.3 Type III

7.3.3 Capacity, Production, Price, Cost, Gross and Revenue

7.3.4 Contact Information

7.4 Pfizer

7.4.1 Company Profile

7.4.2 Product Picture and Specifications

7.4.2.1 Type I

7.4.2.2 Type II

7.4.2.3 Type III

7.4.3 Capacity, Production, Price, Cost, Gross and Revenue

7.4.4 Contact Information

7.5 Sanofi

7.5.1 Company Profile

7.5.2 Product Picture and Specifications

7.5.2.1 Type I

7.5.2.2 Type II

7.5.2.3 Type III

7.5.3 Capacity, Production, Price, Cost, Gross and Revenue

7.5.4 Contact Information

7.6 Bayer

7.6.1 Company Profile

7.6.2 Product Picture and Specifications

7.6.2.1 Type I

7.6.2.2 Type II

7.6.2.3 Type III

7.6.3 Capacity, Production, Price, Cost, Gross and Revenue

7.6.4 Contact Information

7.7 Zoetis

7.7.1 Company Profile

7.7.2 Product Picture and Specifications

7.7.2.1 Type I

7.7.2.2 Type II

7.7.2.3 Type III

7.7.3 Capacity, Production, Price, Cost, Gross and Revenue

7.7.4 Contact Information

7.8 AstraZeneca

7.8.1 Company Profile

7.8.2 Product Picture and Specifications

7.8.2.1 Type I

7.8.2.2 Type II

7.8.2.3 Type III

7.8.3 Capacity, Production, Price, Cost, Gross and Revenue

7.8.4 Contact Information

7.9 Johnson & Johnson

7.9.1 Company Profile

7.9.2 Product Picture and Specifications

7.9.2.1 Type I

7.9.2.2 Type II

7.9.2.3 Type III

7.9.3 Capacity, Production, Price, Cost, Gross and Revenue

7.9.4 Contact Information

7.10 Boehringer Ingelheim

7.10.1 Company Profile

7.10.2 Product Picture and Specifications

7.10.2.1 Type I

7.10.2.2 Type II

7.10.2.3 Type III

7.10.3 Capacity, Production, Price, Cost, Gross and Revenue

7.10.4 Contact Information

8 Price and Gross Margin Analysis

8.1 Analysis of Price

8.2 Gross Margin Analysis

8.3 Price Comparison by Regions

8.4 Price Analysis of Different Polysaccharide vaccines Product Types

8.5 Market Share Analysis of Different Polysaccharide vaccines Price Levels

8.6 Gross Margin Analysis of Different Polysaccharide vaccines Applications

9 Marketing Trader or Distributor Analysis of Polysaccharide vaccines

9.1 Marketing Channels Status of Polysaccharide vaccines

9.2 Traders or Distributors of Polysaccharide vaccines with Contact Information

9.3 Ex-work Price, Channel Price and End Buyer Price Analysis of Polysaccharide vaccines

9.4 United States Import, Export and Trade Analysis of Polysaccharide vaccines

10 Development Trend of Polysaccharide vaccines Industry 2016-2021

10.1 Capacity and Production Overview of Polysaccharide vaccines 2016-2021

10.2 Production Market Share by Product Types of Polysaccharide vaccines 2016-2021

10.3 Sales and Sales Revenue Overview of Polysaccharide vaccines 2016-2021

10.4 United States Sales of Polysaccharide vaccines by Applications 2016-2021

10.5 Import, Export and Consumption of Polysaccharide vaccines 2016-2021

10.6 Cost, Price, Revenue and Gross Margin of Polysaccharide vaccines 2016-2021

11 Industry Chain Suppliers of Polysaccharide vaccines with Contact Information

11.1 Major Raw Materials Suppliers of Polysaccharide vaccines with Contact Information

11.2 Manufacturing Equipment Suppliers of Polysaccharide vaccines with Contact Information

11.3 Major Players of Polysaccharide vaccines with Contact Information

11.4 Key Consumers of Polysaccharide vaccines with Contact Information

11.5 Supply Chain Relationship Analysis of Polysaccharide vaccines

12 New Project Investment Feasibility Analysis of Polysaccharide vaccines

12.1 New Project SWOT Analysis of Polysaccharide vaccines

12.2 New Project Investment Feasibility Analysis of Polysaccharide vaccines

13 Conclusion of the United States Polysaccharide vaccines Industry 2016 Market Research Report

List Of Tables and Figures

Figure Picture of Polysaccharide vaccines

Table Product Specifications of Polysaccharide vaccines

Table Classification of Polysaccharide vaccines

Figure United States Sales Market Share of Polysaccharide vaccines by Product Types in 2015

Table Applications of Polysaccharide vaccines

Figure United States Sales Market Share of Polysaccharide vaccines by Applications in 2015

Figure Industry Chain Structure of Polysaccharide vaccines

Table United States Industry Overview of Polysaccharide vaccines

Table Industry Policy of Polysaccharide vaccines

Table Industry News List of Polysaccharide vaccines

Table Bill of Materials (BOM) of Polysaccharide vaccines

Table Bill of Materials (BOM) Price of Polysaccharide vaccines

Table Labor Cost of Polysaccharide vaccines

Table Depreciation Cost of Polysaccharide vaccines

Table Manufacturing Cost Structure Analysis of Polysaccharide vaccines in 2015

Figure Manufacturing Process Analysis of Polysaccharide vaccines

Table United States Price Analysis of Polysaccharide vaccines 2011-2016 (USD/mL)

Table United States Cost Analysis of Polysaccharide vaccines 2011-2016 (USD/mL)

Table United States Gross Analysis of Polysaccharide vaccines 2011-2016

Table Capacity (mL) and Commercial Production Date of United States Polysaccharide vaccines Key Manufacturers in 2015

Table Manufacturing Plants Distribution of United States Key Polysaccharide vaccines Manufacturers in 2015

Table R&D Status and Technology Source of United States Polysaccharide vaccines Key Manufacturers in 2015

Table Raw Materials Sources Analysis of United States and United States Polysaccharide vaccines Key Manufacturers in 2015

Table United States Production of Polysaccharide vaccines by Regions 2011-2016 (mL)

Table United States Production Market Share of Polysaccharide vaccines by Regions 2011-2016

Figure United States Production Market Share of Polysaccharide vaccines by Regions in 2014

Figure United States Production Market Share of Polysaccharide vaccines by Regions in 2015

Table United States Production of Polysaccharide vaccines by Types in 2011-2016 (mL)

Table United States Production Market Share of Polysaccharide vaccines by Type in 2011-2016

Figure United States Production Market Share of Polysaccharide vaccines by Type in 2014

Figure United States Production Market Share of Polysaccharide vaccines by Type in 2015

Table United States Sales of Polysaccharide vaccines by Applications 2011-2016 (mL)

Table United States Production Market Share of Polysaccharide vaccines by Applications 2011-2016

Figure United States Production Market Share of Polysaccharide vaccines by Applications in 2014

Figure United States Production Market Share of Polysaccharide vaccines by Applications in 2015

Table Price Comparison of United States Polysaccharide vaccines Key Manufacturers in 2015 (USD/mL)

Table United States Capacity, Production, Import Export Sales Price , Cost and Revenue (M USD) of Polysaccharide vaccines 2011-2016

Table United States Consumption Volume of Polysaccharide vaccines by Regions 2011-2016 (mL)

Table United States Consumption Volume Market Share of Polysaccharide vaccines by Regions 2011-2016

Figure United States Consumption Volume Market Share of Polysaccharide vaccines by Regions in 2014

Figure United States Consumption Volume Market Share of Polysaccharide vaccines by Regions in 2015

Table United States Consumption Value of Polysaccharide vaccines by Regions 2011-2016 (M USD)

Table United States Consumption Value Market Share of Polysaccharide vaccines by Regions 2011-2016

Figure United States Consumption Value Market Share of Polysaccharide vaccines by Regions in 2014

Figure United States Consumption Value Market Share of Polysaccharide vaccines by Regions in 2015

Table Consumption Price of Polysaccharide vaccines by Regions 2011-2016 (USD/mL)

Table United States and Major Manufacturers Capacity of Polysaccharide vaccines 2011-2016 (mL)

Table United States Capacity Market Share of Major Polysaccharide vaccines Manufacturers 2011-2016

Table United States and Major Manufacturers Production of Polysaccharide vaccines 2011-2016 (mL)

Table United States Production Market Share of Major Polysaccharide vaccines Manufacturers 2011-2016

Table United States and Major Manufacturers Sales of Polysaccharide vaccines 2011-2016 (mL)

Table United States Sales Market Share of Major Polysaccharide vaccines Manufacturers 2011-2016

Table United States and Major Manufacturers Sales Revenue of Polysaccharide vaccines 2011-2016 (M USD)

Table United States Sales Revenue Market Share of Major Polysaccharide vaccines Manufacturers 2011-2016

Figure United States Capacity (mL), Production (mL) and Growth Rate of Polysaccharide vaccines 2011-2016

Figure United States Capacity Utilization Rate of Polysaccharide vaccines 2011-2016

Figure United States Sales Revenue (M USD) and Growth Rate of Polysaccharide vaccines 2011-2016

Figure United States Production Market Share of Major Polysaccharide vaccines Manufacturers in 2014

Figure United States Production Market Share of Major Polysaccharide vaccines Manufacturers in 2015

Figure United States Sales Market Share of Major Polysaccharide vaccines Manufacturers in 2014

Figure United States Sales Market Share of Major Polysaccharide vaccines Manufacturers in 2015

Figure United States Sales (mL) and Growth Rate of Polysaccharide vaccines 2011-2016

Table United States Supply, Consumption and Gap of Polysaccharide vaccines 2011-2016 (mL)

Table United States Import, Export and Consumption of Polysaccharide vaccines 2011-2016 (mL)

Table Price of United States Polysaccharide vaccines Major Manufacturers 2011-2016 (USD/mL)

Table Gross Margin of United States Polysaccharide vaccines Major Manufacturers 2011-2016

Table United States and Major Manufacturers Revenue of Polysaccharide vaccines 2011-2016 (M USD)

Table United States Capacity (mL), Production (mL), Price (USD/mL), Cost (USD/mL), Revenue (M USD) and Gross Margin of Polysaccharide vaccines 2011-2016

Table GSK Company Profile (Contact Information Plant Location Capacity Revenue etc)

Figure Polysaccharide vaccines Picture and Specifications of GSK

Table Polysaccharide vaccines Capacity (mL), Production (mL), Price (USD/mL), Cost (USD/mL), Gross (USD/mL), Revenue (M USD) and Gross Margin of GSK 2011-2016

Figure Polysaccharide vaccines Capacity (mL), Production (mL) and Growth Rate of GSK 2011-2016

Figure Polysaccharide vaccines Production (mL) and United States Market Share of GSK 2011-2016

Table GSK Polysaccharide vaccines SWOT Analysis

Table Merck Company Profile (Contact Information Plant Location Capacity Revenue etc)

Figure Polysaccharide vaccines Picture and Specifications of Merck

Table Polysaccharide vaccines Capacity (mL), Production (mL), Price (USD/mL), Cost (USD/mL), Gross (USD/mL), Revenue (M USD) and Gross Margin of Merck 2011-2016

Figure Polysaccharide vaccines Capacity (mL), Production (mL) and Growth Rate of Merck 2011-2016

Figure Polysaccharide vaccines Production (mL) and United States Market Share of Merck 2011-2016

Table Merck Polysaccharide vaccines SWOT Analysis

Table Novartis Company Profile (Contact Information Plant Location Capacity Revenue etc)

Figure Polysaccharide vaccines Picture and Specifications of Novartis

Table Polysaccharide vaccines Capacity (mL), Production (mL), Price (USD/mL), Cost (USD/mL), Gross (USD/mL), Revenue (M USD) and Gross Margin of Novartis 2011-2016

Figure Polysaccharide vaccines Capacity (mL), Production (mL) and Growth Rate of Novartis 2011-2016

Figure Polysaccharide vaccines Production (mL) and United States Market Share of Novartis 2011-2016

Table Novartis Polysaccharide vaccines SWOT Analysis

Table Pfizer Company Profile (Contact Information Plant Location Capacity Revenue etc)

Figure Polysaccharide vaccines Picture and Specifications of Pfizer

Table Polysaccharide vaccines Capacity (mL), Production (mL), Price (USD/mL), Cost (USD/mL), Gross (USD/mL), Revenue (M USD) and Gross Margin of Pfizer 2011-2016

Figure Polysaccharide vaccines Capacity (mL), Production (mL) and Growth Rate of Pfizer 2011-2016

Figure Polysaccharide vaccines Production (mL) and United States Market Share of Pfizer 2011-2016

Table Pfizer Polysaccharide vaccines SWOT Analysis

Table Sanofi Company Profile (Contact Information Plant Location Capacity Revenue etc)

Figure Polysaccharide vaccines Picture and Specifications of Sanofi

Table Polysaccharide vaccines Capacity (mL), Production (mL), Price (USD/mL), Cost (USD/mL), Gross (USD/mL), Revenue (M USD) and Gross Margin of Sanofi 2011-2016

Figure Polysaccharide vaccines Capacity (mL), Production (mL) and Growth Rate of Sanofi 2011-2016

Figure Polysaccharide vaccines Production (mL) and United States Market Share of Sanofi 2011-2016

Table Sanofi Polysaccharide vaccines SWOT Analysis

Table Bayer Company Profile (Contact Information Plant Location Capacity Revenue etc)

Figure Polysaccharide vaccines Picture and Specifications of Bayer

Table Polysaccharide vaccines Capacity (mL), Production (mL), Price (USD/mL), Cost (USD/mL), Gross (USD/mL), Revenue (M USD) and Gross Margin of Bayer 2011-2016

Figure Polysaccharide vaccines Capacity (mL), Production (mL) and Growth Rate of Bayer 2011-2016

Figure Polysaccharide vaccines Production (mL) and United States Market Share of Bayer 2011-2016

Table Bayer Polysaccharide vaccines SWOT Analysis

Table Zoetis Company Profile (Contact Information Plant Location Capacity Revenue etc)

Figure Polysaccharide vaccines Picture and Specifications of Zoetis

Table Polysaccharide vaccines Capacity (mL), Production (mL), Price (USD/mL), Cost (USD/mL), Gross (USD/mL), Revenue (M USD) and Gross Margin of Zoetis 2011-2016

Figure Polysaccharide vaccines Capacity (mL), Production (mL) and Growth Rate of Zoetis 2011-2016

Figure Polysaccharide vaccines Production (mL) and United States Market Share of Zoetis 2011-2016

Table Zoetis Polysaccharide vaccines SWOT Analysis

Table AstraZeneca Company Profile (Contact Information Plant Location Capacity Revenue etc)

Figure Polysaccharide vaccines Picture and Specifications of AstraZeneca

Table Polysaccharide vaccines Capacity (mL), Production (mL), Price (USD/mL), Cost (USD/mL), Gross (USD/mL), Revenue (M USD) and Gross Margin of AstraZeneca 2011-2016

Figure Polysaccharide vaccines Capacity (mL), Production (mL) and Growth Rate of AstraZeneca 2011-2016

Figure Polysaccharide vaccines Production (mL) and United States Market Share of AstraZeneca 2011-2016

Table AstraZeneca Polysaccharide vaccines SWOT Analysis

Table Johnson & Johnson Company Profile (Contact Information Plant Location Capacity Revenue etc)

Figure Polysaccharide vaccines Picture and Specifications of Johnson & Johnson

Table Polysaccharide vaccines Capacity (mL), Production (mL), Price (USD/mL), Cost (USD/mL), Gross (USD/mL), Revenue (M USD) and Gross Margin of Johnson & Johnson 2011-2016

Figure Polysaccharide vaccines Capacity (mL), Production (mL) and Growth Rate of Johnson & Johnson 2011-2016

Figure Polysaccharide vaccines Production (mL) and United States Market Share of Johnson & Johnson 2011-2016

Table Johnson & Johnson Polysaccharide vaccines SWOT Analysis

Table Boehringer Ingelheim Company Profile (Contact Information Plant Location Capacity Revenue etc)

Figure Polysaccharide vaccines Picture and Specifications of Boehringer Ingelheim

Table Polysaccharide vaccines Capacity (mL), Production (mL), Price (USD/mL), Cost (USD/mL), Gross (USD/mL), Revenue (M USD) and Gross Margin of Boehringer Ingelheim 2011-2016

Figure Polysaccharide vaccines Capacity (mL), Production (mL) and Growth Rate of Boehringer Ingelheim 2011-2016

Figure Polysaccharide vaccines Production (mL) and United States Market Share of Boehringer Ingelheim 2011-2016

Table Boehringer Ingelheim Polysaccharide vaccines SWOT Analysis

Table Polysaccharide vaccines Price by Regions 2011-2016

Table Polysaccharide vaccines Price by Product Types 2011-2016

Table Polysaccharide vaccines Price by Companies 2011-2016

Table Polysaccharide vaccines Gross Margin by Companies 2011-2016

Table Price Comparison of Polysaccharide vaccines by Regions 2011-2016 (USD/mL)

Table Price of Different Polysaccharide vaccines Product Types (USD/mL)

Table Market Share of Different Polysaccharide vaccines Price Level

Table Gross Margin of Different Polysaccharide vaccines Applications

Table Marketing Channels Status of Polysaccharide vaccines

Table Traders or Distributors of Polysaccharide vaccines with Contact Information

Table Ex-work Price, Channel Price and End Buyer Price of Polysaccharide vaccines (USD/mL) in 2015

Table United States Import, Export, and Trade of Polysaccharide vaccines (mL)

Figure United States Capacity (mL), Production (mL) and Growth Rate of Polysaccharide vaccines 2016-2021

Figure United States Capacity Utilization Rate of Polysaccharide vaccines 2016-2021

Table United States Polysaccharide vaccines Production by Type 2016-2021 (mL)

Table United States Polysaccharide vaccines Production Market Share by Type 2016-2021

Figure United States Production Market Share of Polysaccharide vaccines by Type in 2021

Figure United States Sales (mL) and Growth Rate of Polysaccharide vaccines 2016-2021

Figure United States Sales Revenue (Million USD) and Growth Rate of Polysaccharide vaccines 2016-2021

Figure United States Sales of Polysaccharide vaccines by Applications 2016-2021 (mL)

Table United States Production Market Share of Polysaccharide vaccines by Applications 2016-2021

Figure United States Production Market Share of Polysaccharide vaccines by Applications in 2021

Table United States Production, Import, Export and Consumption of Polysaccharide vaccines 2016-2021 (mL)

Table United States Production (mL), Price (USD/mL), Cost (USD/mL), Revenue (M USD) and Gross Margin of Polysaccharide vaccines 2016-2021

Table Major Raw Materials Suppliers of Polysaccharide vaccines with Contact Information

Table Manufacturing Equipment Suppliers of Polysaccharide vaccines with Contact Information

Table Major Players of Polysaccharide vaccines with Contact Information

Table Key Consumers of Polysaccharide vaccines with Contact Information

Table Supply Chain Relationship Analysis of Polysaccharide vaccines

Table New Project SWOT Analysis of Polysaccharide vaccines

Table New Project Investment Feasibility Analysis of Polysaccharide vaccines

Table Part of Interviewees Record List

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

Protein Therapeutics Market by Product (Monoclonal Antibodies, Insulin, Fusion Protein, Erythropoietin, Interferon, Human Growth Hormone, and Follicle Stimulating Hormone) and Application (Metabolic Disorders, Immunologic Disorders, Hematological Disorders, Cancer, Hormonal Disorders, Genetic Disorders, and Others) - Global Opportunity Analysis and Industry Forecast, 2017-2023

Proteins that are designed and engineered in the laboratory for pharmaceutical interventions to treat different diseases are known as protein therapeutics. The global protein therapeutics market accounted for $140,109 million in 2016, and is anticipated to rea...

  • Publish Date: November 14, 2017
  • $5370
Global Cord Blood Banking Services (Stem Cell) Market, Size, Share, Trends, Forecast, Global Analysis, Research, Report, Segmentation, and Future Demand, 2012 - 2020

Umbilical cord blood bank is storage facility that collects cord blood after the childbirth from placenta. Cord blood is rich source of stem cell used in treatment of different chronic diseases. Private and public cord blood banks are the two major types of banks that are prevalent in th...

  • Publish Date: July 20, 2017
  • $5370